Biogen Idec To Collaborate With Isis On Treatment For Degenerative Muscle Disorder
This article was originally published in The Pink Sheet Daily
Executive Summary
The two companies build on an existing partnership in spinal muscular atrophy to address another muscle-wasting disease. For the second time, they’ve arranged an option deal, with milestones built in both before and after licensing.